• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ensuring Access to New Treatments for Ebola Virus Disease (Report) - MSF/Doctors Without Borders

Mary Wilson

Well-known member
24 MAY 2023

After nearly half a century without any treatments, the world now has two approved treatments for Ebola virus disease (EVD) – mAb114 and REGN-EB3. The approval of these treatments was the outcome of a collective effort, comprising contributions by patients and survivors, the US and European governments, countries affected by EVD, pharmaceutical corporations, the World Health Organization and non-governmental organisations (NGOs).

However, more than two years after their approval, the process of ensuring that people who need these treatments can access them is at a standstill. ...

https://msfaccess.org/ensuring-access-new-treatments-ebola-virus-disease
 
Back
Top